News

Researchers discover a highly potent biomarker for clinical response to CAR-T cell therapy

0
Close Up Scientist using microscope in laboratory room while making medical testing and research

A MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for lymphoma treatment.

Study suggests air pollution is an important independent risk factor for asthma exacerbations in children living in urban areas

Previous article

Visualizing the inside of cells at previously impossible resolutions

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News